Lorena V. N. Oliveira

Author

Universidade Federal de Minas Gerais ORCID

Also Known As

L. V. N. Oliveira, Lorena Oliveira, Lorena V. N. Oliveira, Lorena V.N. Oliveira, Lorena Vivien Neves Oliveira, Lorena Vívien Neves Oliveira, Lorena Vívien Neves de Oliveira, Lorena Vívien Oliveira

Publications

485

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Minas Gerais University of Massachusetts Chan Medical School Universidade de São Paulo Universidade Federal de Juiz de Fora Fundação Oswaldo Cruz

About

Lorena V. N. Oliveira is an author at Universidade Federal de Minas Gerais specializing in medicine, microbiology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	125
2	Microbiology	3	3	74
3	Health Sciences	2	2	42
4	Pharmacology	2	2	65
5	Clinical Microbiology	2	2	42

Lorena V. N. Oliveira

Publications

298

Citations

H-Index

Page 1

	Year	Citations
Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans Rafael Wesley Bastos, Hellem Cristina Silva Carneiro, Lorena V. N. Oliveira, Antimicrobial Agents and Chemotherapy	2017	67
Atorvastatin as a promising anticryptococcal agent Noelly de Queiroz Ribeiro, Marliete Carvalho da Costa, Thaís Furtado Ferreira Magalhães, International Journal of Antimicrobial Agents Medicinal ChemistryPharmaceutical ScienceMedicinePromising Anticryptococcal AgentClinical Pharmacology	2017	51
Influenza A Virus as a Predisposing Factor for Cryptococcosis Lorena V. N. Oliveira, Marliete Carvalho da Costa, Thais F.F. Magalhães, Frontiers in Cellular and Infection Microbiology	2017	35
From the environment to the host: How non-azole agrochemical exposure affects the antifungal susceptibility and virulence of Cryptococcus gattii Rafael Wesley Bastos, Gustavo José Cota de Freitas, Hellem Cristina Silva Carneiro, The Science of The Total Environment Antifungal AgentAntimicrobial SusceptibilityCryptococcus GattiiAntifungal SusceptibilityMicrobiology	2019	32
Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii Hellem Cristina Silva Carneiro, Rafael Wesley Bastos, Noelly Queiroz Ribeiro, The Science of The Total Environment Antifungal AgentHealth SciencesCryptococcus GattiiAntifungal AgentsEnvironmental Fungicide	2020	28
Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases Ruiying Wang, Lorena V. N. Oliveira, Diana Lourenco, npj Vaccines	2023	21
Immunological correlates of protection mediated by a whole organism, <i>Cryptococcus neoformans</i> , vaccine deficient in chitosan Charles A. Specht, Ruiying Wang, Lorena V. N. Oliveira, mBio	2024	15
Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii F. E. S. Mendes, Lorena V. N. Oliveira, Elaine Speziali de Faria, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentAntimicrobial SusceptibilityHealth SciencesCryptococcus GattiiAntifungal Agents	2010	14
Dysregulated pulmonary inflammatory responses exacerbate the outcome of secondary aspergillosis following influenza Chrono K. Lee, Lorena V. N. Oliveira, Ali Akalin, mBio	2023	13
Pseudomonas aeruginosa Infection Modulates the Immune Response and Increases Mice Resistance to Cryptococcus gattii Eluzia Castro Peres-Emidio, Gustavo José Cota de Freitas, Marliete Carvalho da Costa, Frontiers in Cellular and Infection Microbiology	2022	11

Page 1